PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 19 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Lacks controlled clinical trials to support its use [PMID:10516985]
In vitro evidence shows inhibition of NLRP3 inflammasome and increased phagocytic activity of macrophages toward amyloid-β [PMID:40536624]
Significantly stimulates gastric acid secretion [PMID:3508643]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 10516985 (1999) — Nutrition and dietary supplements. · Physical medicine and rehabilitation clinics of North America
- 2.PMID: 40536624 (2025) — Cola acuminata extract's inhibition of NLRP3 inflammasome in THP-1 cells as a potential treatment option for Parkinson's disease. · Metabolic brain disease
- 3.PMID: 24511707 (2013) — Proximate and phytochemical of Cola nitida and Cola acuminata. · Pakistan journal of biological sciences : PJBS
- 4.PMID: 19394393 (2009) — Safety assessment of kola nut extract as a food ingredient. · Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
- 5.PMID: 7672735 (1995)